Skip to main content

Blastic Plasmacytoid Dendritic Cell Neoplasm News

Related terms: BPDCN, Natural Killer (NK) Cell Leukemia/Lymphoma

FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy

NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Acute Myeloid Leukemia